Bayer’s Consumer Health Sales Stay Cool During Summer Months
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.